Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Total revenues	$ 29,078	$ 19,221	$ 55,045	$ 30,691
Costs and expenses:
Cost of sales	2,947	2,236	5,753	3,657
Research and development	30,194	33,543	158,858	71,487
Selling, general, and administrative	36,415	30,046	70,797	54,674
Total costs and expenses	69,556	65,825	235,408	129,818
Loss from operations	(40,478)	(46,604)	(180,363)	(99,127)
Other income (expense):
Other income (expense), net	302	(17)	824	34
Gain on settlement of forward contract	8,900		8,900
Interest expense	(4,603)	(3,303)	(9,358)	(6,449)
Interest income	4,097	3,221	7,143	6,660
Total other income (expense), net	8,696	(99)	7,509	245
Loss before income taxes	(31,782)	(46,703)	(172,854)	(98,882)
Provision for income taxes	479		779
Net loss	(32,261)	(46,703)	(173,633)	(98,882)
Accrued dividends on convertible preferred stock	(1,302)		(1,302)
Net loss attributable to common stockholders	$ (33,563)	$ (46,703)	$ (174,935)	$ (98,882)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.55)	$ (0.82)	$ (2.89)	$ (1.74)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.55)	$ (0.82)	$ (2.89)	$ (1.74)
Weighted-average common shares outstanding, basic (in shares)	61,011,824	56,867,662	60,577,691	56,788,757
Weighted-average common shares outstanding, diluted (in shares)	61,011,824	56,867,662	60,577,691	56,788,757
Other comprehensive loss:
Net loss attributable to common stockholders	$ (33,563)	$ (46,703)	$ (174,935)	$ (98,882)
Foreign currency translation adjustment	(302)	(48)	(373)	(27)
Unrealized (loss) gain, net on marketable securities, net of tax	(134)	40	(378)	105
Comprehensive loss	(33,999)	(46,711)	(175,686)	(98,804)
Product revenue, net
Total revenues	$ 29,078	$ 19,221	$ 55,045	$ 30,691